Document is current
Any future updates will be listed below
-
Authors
Knox, Ruth
Smith, Rachel https://orcid.org/0000-0002-4665-7003
Kempa, Emily E. https://orcid.org/0000-0001-6481-7974
Spiess, Reynard https://orcid.org/0009-0004-4692-9787
Schnepel, Christian https://orcid.org/0000-0002-4331-2675
Turner, Nicholas J. https://orcid.org/0000-0002-8708-0781
Flitsch, Sabine L. https://orcid.org/0000-0003-3974-646X
Barran, Perdita E. https://orcid.org/0000-0002-7720-586X
-
Funding
Funding for this research was provided by:
RCUK | Engineering and Physical Sciences Research Council (EP/S005226/1, EP/T019328/1)
RCUK | Biotechnology and Biological Sciences Research Council (BB/M017702/1)
- License Information
-
More Information
Article History
Received: 29 June 2022
Accepted: 17 February 2025
First Online: 21 April 2025
Competing interests
: E.E.K. is an employee of AstraZeneca and owns or has the option to own stocks in this company.
